Heart Test Laboratories, Inc. (NASDAQ:HSCS) Short Interest Update

Heart Test Laboratories, Inc. (NASDAQ:HSCS) saw a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 30,500 shares, an increase of 32.0% from the October 31st total of 23,100 shares. Based on an average trading volume of 356,800 shares, the days-to-cover ratio is currently 0.1 days. Approximately 3.7% of the shares of the company are sold short.

Analyst Ratings Changes

Separately, Ascendiant Capital Markets reiterated a “buy” rating and issued a $15.00 price target on shares of Heart Test Laboratories in a research note on Monday, September 23rd.

Heart Test Laboratories Trading Up 1.7 %

NASDAQ:HSCS traded up $0.05 during mid-day trading on Friday, hitting $2.95. 10,912 shares of the stock traded hands, compared to its average volume of 135,732. The company has a quick ratio of 4.02, a current ratio of 4.49 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $2.69 million, a price-to-earnings ratio of -0.14 and a beta of 3.27. Heart Test Laboratories has a 52 week low of $2.36 and a 52 week high of $25.09. The firm’s 50 day moving average is $3.38 and its two-hundred day moving average is $4.08.

Heart Test Laboratories (NASDAQ:HSCS) last posted its quarterly earnings results on Thursday, September 12th. The company reported ($2.64) earnings per share for the quarter. On average, equities research analysts predict that Heart Test Laboratories will post -9.82 earnings per share for the current year.

About Heart Test Laboratories

Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals.